首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >Is there a decrease in Guillain-Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy.
【24h】

Is there a decrease in Guillain-Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy.

机译:在意大利服用牛神经节苷脂后,格林-巴利综合征的发病率是否有所降低?意大利费拉拉地方卫生区的一项基于人口的研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

There have been many reports of cases of Guillain-Barre syndrome (GBS) after therapeutic injection of bovine ganglioside preparations with the result that they were withdrawn in Italy in December 1993. As the relationship between bovine gangliosides and GBS has not yet been established, a further epidemiological investigation in the Local Health District (LHD) of Ferrara, Italy, was carried out in the years 1994-2001 to verify whether the incidence of GBS had changed after ganglioside withdrawal. The other aim of this investigation was to update the incidence of GBS in this area since the two previous investigations we carried out showed an increase in incidence from the years 1981-1987 to the years 1988-1993. The cases of GBS were identified prospectively. To guarantee completeness of case ascertainment, an intensive retrospective survey of all possible sources of cases for the entire study period was performed. The mean annual crude incidence rate in the years 1994-2001 (based on 26 new cases) was 1.97 per 100,000 population (95% CI 1.29-2.89), whereas it had been 1.87 per 100,000 population (95% CI 1.35-2.52) in the years 1981-1993 (based on 43 cases) when gangliosides were available. The age-adjusted rates were almost identical (1.66 and 1.65 per 100,000 population, respectively). Although ganglioside administration could have triggered, on the basis of an individual susceptibility, an immunologic reaction which produced GBS, the incidence of GBS in the study area did not change after ganglioside withdrawal. In the whole period 1981-2001, a temporal pattern of incidence was reported with an increase towards a peak in 1990-1992 and a progressive decline thereafter. This temporal pattern did not seem related to ganglioside withdrawal, and no definite explanation for it was found which could imply that the disease incidence is less stable than it was deemed.
机译:有许多报道称,在治疗性注射牛神经节苷脂制剂后发生了格林-巴利综合症(GBS),结果于1993年12月在意大利被撤回。由于尚未建立牛神经节苷脂与GBS之间的关系, 1994年至2001年,意大利费拉拉地方卫生区(LHD)进行了进一步的流行病学调查,以验证神经节苷脂撤药后GBS的发生率是否发生了变化。这项调查的另一个目的是更新该地区GBS的发生率,因为我们进行的前两次调查显示,从1981-1987年到1988-1993年,其发生率有所增加。前瞻性鉴定了GBS病例。为了确保案件确定的完整性,在整个研究期间对所有可能的案件来源进行了深入的回顾性调查。 1994-2001年(基于26个新病例)的年平均原油发生率是每100,000人口1.97(95%CI 1.29-2.89),而在1991年是100,000人口1.87(95%CI 1.35-2.52)。 1981-1993年(基于43例病例)可使用神经节苷脂。年龄调整后的比率几乎相同(分别为每100,000人口1.66和1.65)。尽管基于个体的敏感性,神经节苷脂的给药可能会触发产生GBS的免疫反应,但是在神经节苷脂戒断后研究区域内GBS的发生率并没有改变。在整个1981-2001年期间,据报告发病率呈时间上的变化,在1990-1992年达到峰值,然后逐渐下降。这种时间上的变化似乎与神经节苷脂的戒断没有关系,也没有明确的解释,这可能意味着该疾病的发病率不如人们认为的稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号